OPTICORE Trademark

Trademark Overview

On Friday, June 18, 2021, a trademark application was filed for OPTICORE with the United States Patent and Trademark Office. The USPTO has given the OPTICORE trademark a serial number of 79316342. The federal status of this trademark filing is REGISTERED as of Tuesday, December 20, 2022. This trademark is owned by Tillotts Pharma AG. The OPTICORE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, preparations for the prevention and treatment of gastrointestinal disorders; diagnostic products for medical use, namely, diagnostic preparations for medical use
opticore

General Information

Serial Number79316342
Word MarkOPTICORE
Filing DateFriday, June 18, 2021
Status700 - REGISTERED
Status DateTuesday, December 20, 2022
Registration Number6926789
Registration DateTuesday, December 20, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, preparations for the prevention and treatment of gastrointestinal disorders; diagnostic products for medical use, namely, diagnostic preparations for medical use
Pseudo MarkOPTI CORE; OPTIC CORE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTillotts Pharma AG
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressCH
Party NameTillotts Pharma AG
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressCH
Party NameTillotts Pharma AG
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressCH

Trademark Events

Event DateEvent Description
Thursday, August 10, 2023INTERNATIONAL REGISTRATION RENEWED
Monday, April 24, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, April 3, 2023FINAL DISPOSITION NOTICE SENT TO IB
Monday, April 3, 2023FINAL DISPOSITION PROCESSED
Monday, March 20, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 20, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 20, 2022REGISTERED-PRINCIPAL REGISTER
Sunday, October 9, 2022NOTIFICATION PROCESSED BY IB
Tuesday, October 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2022PUBLISHED FOR OPPOSITION
Wednesday, September 14, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 14, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 24, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 24, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 24, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 9, 2022REFUSAL PROCESSED BY IB
Wednesday, April 13, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, April 13, 2022REFUSAL PROCESSED BY MPU
Friday, March 11, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, March 10, 2022NON-FINAL ACTION WRITTEN
Thursday, March 10, 2022ASSIGNED TO EXAMINER
Friday, July 30, 2021APPLICATION FILING RECEIPT MAILED
Monday, July 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 22, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

opticore preparations diagnostic medical namely disorders products treatment prevention pharmaceutical gastrointestinal